Intensive Care Department, Alfred Hospital, Melbourne, VIC.
Crit Care Resusc. 2009 Dec;11(4):244-9.
To assess and describe postoperative complications of single dilator percutaneous dilatational tracheostomy (PDT) and surgical tracheostomy (ST) in a large series of critically ill patients.
A prospective observational study was conducted in 1163 critically ill patients in a university affiliated tertiary referral hospital between 2002 and 2007. PDT was the procedure of choice for all critically ill patients requiring tracheostomy except for those with an anatomic abnormality or refractory coagulopathy, who underwent ST. Demographic and postoperative complication data were collected in a web-based database.
913 patients (79%) underwent PDT at the bedside in the ICU, and 250 (21%) underwent ST in the operating theatre. The tracheostomy tube was larger, and the duration of tracheostomy cannulation was shorter after PDT than after ST. The postoperative complication rate for PDT was 9.6% compared with 19.6% for ST (P<0.001). Tracheal tube obstruction and displacement were significantly less frequent after PDT (obstruction 1.0% for PDT v 3.6% for ST, P = 0.007; displacement, 1.3% for PDT v 4.8% for ST, P = 0.002).
In a large heterogeneous group of critically ill patients, single dilator PDT was safe and had few postoperative complications. Although ST was used in higher-risk patients, those who underwent PDT were more likely to receive a larger-sized tracheostomy tube; they were also less likely to experience obstruction or displacement of the postoperative tracheostomy tube. These differences are probably related to a combination of patient selection, smaller, shorter tracheostomy tubes, and larger tissue incision size with ST.
在一个大型的危重症患者群体中,评估并描述单扩张器经皮扩张气管切开术(PDT)和外科气管切开术(ST)的术后并发症。
这是一项在 2002 年至 2007 年间于一所大学附属医院的三级转诊医院进行的前瞻性观察性研究。PDT 是所有需要气管切开术的危重症患者的首选方法,除了那些存在解剖异常或难治性凝血功能障碍的患者,他们需要接受 ST。在一个基于网络的数据库中收集了人口统计学和术后并发症数据。
913 例(79%)患者在 ICU 床边接受 PDT,250 例(21%)患者在手术室接受 ST。PDT 后的气管切开管更大,且气管切开插管时间更短。PDT 的术后并发症发生率为 9.6%,而 ST 为 19.6%(P<0.001)。PDT 后气管导管阻塞和移位的发生率明显更低(阻塞发生率:PDT 为 1.0%,ST 为 3.6%,P=0.007;移位发生率:PDT 为 1.3%,ST 为 4.8%,P=0.002)。
在一个大型的、异质的危重症患者群体中,单扩张器 PDT 是安全的,且术后并发症较少。虽然 ST 用于高危患者,但接受 PDT 的患者更有可能接受更大尺寸的气管切开管;他们也不太可能出现术后气管切开管的阻塞或移位。这些差异可能与患者选择、更小、更短的气管切开管以及 ST 时更大的组织切口大小有关。